HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The pharmacokinetics and pharmacodynamics of GW395058, a peptide agonist of the thrombopoietin receptor, in the dog, a large-animal model of chemotherapy-induced thrombocytopenia.

Abstract
GW395058, a PEGylated peptide agonist of the thrombopoietin receptor, stimulates megakaryocytopoiesis and has previously been shown to increase platelet counts in vivo. The pharmacokinetics and pharmacodynamics of GW395058 were characterized using a randomized, crossover study in a large-animal model (dog) of chemotherapy-induced thrombocytopenia. Nine beagle dogs received i.v. carboplatin (350 mg/m(2)) on day 0 and day 28. GW395058 (1.31 mg/kg) (n = 6) or vehicle control (n = 3) was administered on day 1 and day 29 either as an i.v. bolus or s.c. injection. After i.v. administration, peak concentrations of GW395058 occurred rapidly, while the half-life averaged approximately 56 h. Bioavailability (+/- standard deviation) of GW395058 given s.c. was 78.2% (20.9%). GW395058 (i.v. and s.c.) ameliorated the platelet nadir (p = 0.0086) and resulted in a shorter time to recovery compared to the control group. The mean nadir platelet counts following carboplatin administration were 197,000 cells/microl (80,000) for the i.v. GW395058-dose group, 183,000 cells/microl (72,000) for the s.c.-dose group and 71,000 cells/microl (38,000) for the vehicle-alone group. GW395058 reduced the thrombocytopenic effects of carboplatin in dogs. No GW395058-related adverse side effects were observed.
AuthorsB C Case, M L Hauck, R L Yeager, A H Simkins, M de Serres, V D Schmith, J E Dillberger, R L Page
JournalStem cells (Dayton, Ohio) (Stem Cells) Vol. 18 Issue 5 Pg. 360-5 ( 2000) ISSN: 1066-5099 [Print] England
PMID11007920 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • GW395058
  • Neoplasm Proteins
  • Peptides
  • Proto-Oncogene Proteins
  • Receptors, Cytokine
  • Receptors, Thrombopoietin
  • MPL protein, human
  • Thrombopoietin
  • Carboplatin
Topics
  • Animals
  • Carboplatin (toxicity)
  • Dogs
  • Female
  • Injections, Intravenous
  • Injections, Subcutaneous
  • Leukocyte Count (drug effects)
  • Male
  • Metabolic Clearance Rate
  • Molecular Mimicry
  • Neoplasm Proteins
  • Neutrophils (drug effects)
  • Peptides (blood, pharmacokinetics, pharmacology)
  • Platelet Count (drug effects)
  • Proto-Oncogene Proteins (agonists, physiology)
  • Receptors, Cytokine
  • Receptors, Thrombopoietin
  • Thrombocytopenia (blood, chemically induced, therapy)
  • Thrombopoietin (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: